Rising consumption of illegal drugs is resulting into increase in the requirement for drug abuse tests. This is one of the prominent factors creating revenue-generating opportunities in the global drugs of abuse testing market, which is expected to register growth at a CAGR of 5.7% during the forecast period from 2019 to 2027, note analysts at Transparency Market Research (TMR). Hence, it is prognosticated to gain a valuation of US$ 7.6 Bn by 2027.
The study by TMR provides 360-degree analysis of factors shaping the growth of drugs of abuse testing market. Moreover, this report delivers exclusive study of growth drivers, restraints, challenges, R&D activities, key regions, and competition landscape of the market for drugs of abuse testing.
The researchers of report by TMR have segmented all data and analysis of the global drugs of abuse testing market based on many important facets such as sample type, testing type, end-user, and region.
In terms of sample type, the market for drugs of abuse testing is classified into breath, saliva, blood, hair & sweat, and urine. Based on testing type, the drugs of abuse testing market is divided into criminal justice testing, workplace testing, and pain management testing. On the basis of end-user, the classification of the market for drugs of abuse testing is performed into diagnostics laboratories, hospitals, forensic laboratories, and on-the-spot testing.
In recent years, several nations across the globe including the U.S. are experiencing increased cases and death rates due to abuse of prescription drugs or nonmedical utilization of prescription drugs.
The National Institute of Drug Abuse (NIDA) states that approximately 52 million people have utilized prescription drugs for nonmedical reasons for minimum one time in their lifetime. Besides, youth populace from across the globe is seen increasing the use of several pain relievers such as OxyContin and Vicodin, which are considered abused prescription drugs. Due to incorrect prescription and addiction to prescription drugs, there is notable increase in comorbid illnesses among older population. Hence, continuous increase in the abuse of prescription drugs is increasing the sales of drugs of abuse testing products.
People consuming illicit drugs tend to be less productive at work, change their jobs frequently, and they frequently absent at workplaces. These factors can result into increased risks of workplace accidents. As a result, many organizations across the globe are emphasizing on regularly performing drugs of abuse tests. Hence, the demand for drug abuse testing by public and private employers is estimated to increase in the years to come.
Europe, North America, Middle East and Africa, Asia Pacific, and Latin America are some of the key regions of the drugs of abuse testing market. Of them, North America is dominant region in the market.
The market is estimated to gain promising sales opportunities in North America in years to come owing to factors such as rise in consumption of illicit drugs and the increase in the availability of insurance plans intended for expensive diagnosis tests in the region.
The nature of the global drugs of abuse testing market is highly fragmented due to existence of several international level players. This scenario represents the highly intense level of competition in the market.
Companies in the drugs of abuse testing market are using different strategies such as acquisitions, collaborations, regulatory approvals, and new products launches. Moreover, several enterprises are increasing investments in R&D projects to develop advanced products. Such initiatives are projected to help in the expansion of the drugs of abuse testing market.
Some key players operating in the drugs of abuse testing market are Laboratory Corporation of America Holdings, Alere Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Healthineers, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Express Diagnostics International Inc.
Drugs of Abuse Testing Market was valued at US$ 6 Bn in 2018 and is anticipated to reach at a US$ 7.6 Bn By 2027
Drugs of Abuse Testing Market is anticipated to grow at a CAGR of 5.7% during the forecast period
Drugs of Abuse Testing Market is driven by increasing consumption of illicit drugs, thereby creating demand for drug abuse tests
The analyzers segment dominated the global drugs of abuse testing market in 2018 and the trend is projected to continue during the forecast period
Key players in the global drugs of abuse testing market include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthineers, Express Diagnostics International Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drugs of Abuse Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Regulatory Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Trends
4.5. Market Revenue Projections (US$ Mn)
4.6. Market Outlook
4.7. Porter’s Five Forces Analysis
4.8. Value Chain Analysis
4.9. Technology Assessment
4.10. Global Demand and Supply Scenario
5. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type
5.1. Introduction
5.2. Product Comparison Matrix
5.3. Market Revenue Share (%) and Attractiveness Analysis, by Product Type
5.4. Market Size (US$ Mn) Forecast, by Product Type, 2017 - 2019
5.4.1. Analyzers
5.4.1.1. Immunoassay Analyzers
5.4.1.2. Chromatographic Devices
5.4.1.3. Breath Analyzers
5.4.2. Rapid Testing Devices
5.4.2.1. Urine Testing Devices
5.4.2.2. Oral Fluid Testing Devices
5.4.3. Consumables
5.4.3.1. Fluid Collection Devices
5.4.3.2. Others
6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type
6.1. Introduction
6.2. Market Revenue Share (%) and Attractiveness Analysis, by Sample Type
6.3. Market Size (US$ Mn) Forecast, by Sample Type, 2017 - 2019
6.3.1. Saliva
6.3.2. Breath
6.3.3. Urine
6.3.4. Blood
6.3.5. Hair & Sweat
7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type
7.1. Introduction
7.2. Market Revenue Share (%) and Attractiveness Analysis, by Testing Type
7.3. Market Size (US$ Mn) Forecast, by Testing Type, 2017 - 2019
7.3.1. Pain Management Testing
7.3.2. Criminal Justice Testing
7.3.3. Workplace Screening
8. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user
8.1. Introduction
8.2. Market Revenue Share (%) and Attractiveness Analysis, by End-user
8.3. Market Size (US$ Mn) Forecast, by End-user, 2017 - 2019
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. On-the-spot Testing
8.3.4. Forensic Laboratories
9. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region
9.1. Market Revenue Share (%) and Attractiveness Analysis, by Region
9.2. Market Size (US$ Mn) Forecast, by Region, 2017 - 2019
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East and Africa
10. North America Drugs of Abuse Testing Market Analysis and Forecast
10.1. Market Overview
10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
10.2. Market Value Share Analysis, by Product Type, 2018 and 2027
10.2.1. Analyzers
10.2.1.1. Immunoassay Analyzers
10.2.1.2. Chromatographic Devices
10.2.1.3. Breath Analyzers
10.2.2. Rapid Testing Devices
10.2.2.1. Urine Testing Devices
10.2.2.2. Oral Fluid Testing Devices
10.2.3. Consumables
10.2.3.1. Fluid Collection Devices
10.2.3.2. Others
10.3. Market Value Share Analysis, by Sample Type, 2018 and 2027
10.3.1. Saliva
10.3.2. Breath
10.3.3. Urine
10.3.4. Blood
10.3.5. Hair & Sweat
10.4. Market Value Share Analysis, by Testing Type, 2018 and 2027
10.4.1. Pain Management
10.4.2. Criminal Justice Testing
10.4.3. Workplace Screening
10.5. Market Value Share Analysis, by End-user, 2018 and 2027
10.5.1. Hospitals
10.5.2. Diagnostics Laboratories
10.5.3. On-The-Spot Testing
10.5.4. Forensic Laboratories
10.6. Market Value Share Analysis, by Country, 2018 and 2027
10.6.1. U.S.
10.6.2. Canada
10.7. Market Size (US$ Mn) Forecast, 2017 - 2019
10.7.1. By Product Type
10.7.2. By Sample Type
10.7.3. By Testing Type
10.7.4. By End-user
10.7.5. By Country
10.8. Market Attractiveness Analysis, 2017 - 2019
10.8.1. By Product Type
10.8.2. By Sample Type
10.8.3. By Testing Type
10.8.4. By End-user
10.8.5. By Country
11. Europe Drugs of Abuse Testing Market Analysis and Forecast
11.1. Market Overview
11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
11.2. Market Value Share Analysis, by Product Type, 2018 and 2027
11.2.1. Analyzers
11.2.1.1. Immunoassay Analyzers
11.2.1.2. Chromatographic Devices
11.2.1.3. Breath Analyzers
11.2.2. Rapid Testing Devices
11.2.2.1. Urine Testing Devices
11.2.2.2. Oral Fluid Testing Devices
11.2.3. Consumables
11.2.3.1. Fluid Collection Devices
11.2.3.2. Others
11.3. Market Value Share Analysis, by Sample Type, 2018 and 2027
11.3.1. Saliva
11.3.2. Breath
11.3.3. Urine
11.3.4. Blood
11.3.5. Hair & Sweat
11.4. Market Value Share Analysis, by Testing Type, 2018 and 2027
11.4.1. Pain Management
11.4.2. Criminal Justice Testing
11.4.3. Workplace Screening
11.5. Market Value Share Analysis, by End-user, 2018 and 2027
11.5.1. Hospitals
11.5.2. Diagnostics Laboratories
11.5.3. On-the-Spot Testing
11.5.4. Forensic Laboratories
11.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
11.6.1. U.K.
11.6.2. France
11.6.3. Germany
11.6.4. Italy
11.6.5. Spain
11.6.6. Russia
11.6.7. Rest of Europe
11.7. Market Size (US$ Mn) Forecast, 2017 - 2019
11.7.1. By Product Type
11.7.2. By Sample Type
11.7.3. By Testing Type
11.7.4. By End-user
11.7.5. By Country/Sub-region
11.8. Market Attractiveness Analysis, 2017 - 2019
11.8.1. By Product Type
11.8.2. By Sample Type
11.8.3. By Testing Type
11.8.4. By End-user
12. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast
12.1. Market Overview
12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
12.2. Market Value Share Analysis, by Product Type, 2018 and 2027
12.2.1. Analyzers
12.2.1.1. Immunoassay Analyzers
12.2.1.2. Chromatographic Devices
12.2.1.3. Breath Analyzers
12.2.2. Rapid Testing Devices
12.2.2.1. Urine Testing Devices
12.2.2.2. Oral Fluid Testing Devices
12.2.3. Consumables
12.2.3.1. Fluid Collection Devices
12.2.3.2. Others
12.3. Market Value Share Analysis, by Sample Type, 2018 and 2027
12.3.1. Saliva
12.3.2. Breath
12.3.3. Urine
12.3.4. Blood
12.3.5. Hair & Sweat
12.4. Market Value Share Analysis, by Testing Type, 2018 and 2027
12.4.1. Pain Management
12.4.2. Criminal Justice Testing
12.4.3. Workplace Screening
12.5. Market Value Share Analysis, by End-user, 2018 and 2027
12.5.1. Hospitals
12.5.2. Diagnostics Laboratories
12.5.3. On-the-Spot Testing
12.5.4. Forensic Laboratories
12.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
12.6.1. Japan
12.6.2. China
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Size (US$ Mn) Forecast, 2017 - 2019
12.7.1. By Product Type
12.7.2. By Sample Type
12.7.3. By Testing Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
12.8. Market Attractiveness Analysis, 2017 - 2019
12.8.1. By Product Type
12.8.2. By Sample Type
12.8.3. By Testing Type
12.8.4. By End-user
13. Latin America Drugs of Abuse Testing Market Analysis and Forecast
13.1. Market Overview
13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
13.2. Market Value Share Analysis, by Product Type, 2018 and 2027
13.2.1. Analyzers
13.2.1.1. Immunoassay Analyzers
13.2.1.2. Chromatographic Devices
13.2.1.3. Breath Analyzers
13.2.2. Rapid Testing Devices
13.2.2.1. Urine Testing Devices
13.2.2.2. Oral Fluid Testing Devices
13.2.3. Consumables
13.2.3.1. Fluid Collection Devices
13.2.3.2. Others
13.3. Market Value Share Analysis, by Sample Type, 2018 and 2027
13.3.1. Saliva
13.3.2. Breath
13.3.3. Urine
13.3.4. Blood
13.3.5. Hair & Sweat
13.4. Market Value Share Analysis, by Testing Type, 2018 and 2027
13.4.1. Pain Management
13.4.2. Criminal Justice Testing
13.4.3. Workplace Screening
13.5. Market Value Share Analysis, by End-user, 2018 and 2027
13.5.1. Hospitals
13.5.2. Diagnostics Laboratories
13.5.3. On-the-Spot Testing
13.5.4. Forensic Laboratories
13.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
13.6.1. Mexico
13.6.2. Brazil
13.6.3. Rest of Latin America
13.7. Market Size (US$ Mn) Forecast, 2017 - 2019
13.7.1. By Product Type
13.7.2. By Sample Type
13.7.3. By Testing Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
13.8. Market Attractiveness Analysis, 2017 - 2019
13.8.1. By Product Type
13.8.2. By Sample Type
13.8.3. By Testing Type
14. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast
14.1. Market Overview
14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
14.2. Market Value Share Analysis, by Product Type, 2018 and 2027
14.2.1. Analyzers
14.2.1.1. Immunoassay Analyzers
14.2.1.2. Chromatographic Devices
14.2.1.3. Breath Analyzers
14.2.2. Rapid Testing Devices
14.2.2.1. Urine Testing Devices
14.2.2.2. Oral Fluid Testing Devices
14.2.3. Consumables
14.2.3.1. Fluid Collection Devices
14.2.3.2. Others
14.3. Market Value Share Analysis, by Sample Type, 2018 and 2027
14.3.1. Saliva
14.3.2. Breath
14.3.3. Urine
14.3.4. Blood
14.3.5. Hair & Sweat
14.4. Market Value Share Analysis, by Testing Type, 2018 and 2027
14.4.1. Pain Management
14.4.2. Criminal Justice Testing
14.4.3. Workplace Screening
14.5. Market Value Share Analysis, by End-user, 2018 and 2027
14.5.1. Hospitals
14.5.2. Diagnostics Laboratories
14.5.3. On-the-Spot Testing
14.5.4. Forensic Laboratories
14.6. Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Size (US$ Mn) Forecast, 2019-2027
14.7.1. By Product Type
14.7.2. By Sample Type
14.7.3. By Testing Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
14.8. Market Attractiveness Analysis, 2017 - 2019
14.8.1. By Product Type
14.8.2. By Sample Type
14.8.3. By Testing Type
14.8.4. By End-user
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company (2018)
15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Siemens Healthineers (Siemens AG)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Shimadzu Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Laboratory Corporation of America Holdings
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Danaher
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Drägerwerk AG & Co. KGaA
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Express Diagnostics International, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
List of Table
Table 1: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 2: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 3: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 4: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 5: Global Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 6: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 7: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 8: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 9: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 10: North America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 12: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 13: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 14: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 15: Europe Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 16: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 17: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 18: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 19: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 20: Asia Pacific Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 22: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 23: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 24: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 25: Latin America Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017 – 2027
Table 26: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2017–2027
Table 27: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2017 – 2027
Table 28: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2017 – 2027
Table 29: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2017 – 2027
Table 30: MEA Drugs of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2017–2027
List of Figure
Figure 1 Figure 01: Global Drugs of Abuse Testing Market Size Value (US$ Mn) Forecast, 2017–2027
Figure 2 Figure 02: Global Drugs of Abuse Testing Market Value Share (%), by Product Type (2017)
Figure 3 Figure 03: Global Drugs of Abuse Testing Market Value Share (%), by Sample Type (2017)
Figure 4 Figure 04: Global Drugs of Abuse Testing Market Value Share (%), by Testing Type (2017)
Figure 5 Figure 05: Global Drugs of Abuse Testing Market Value Share (%), by End-user (2017)
Figure 6 Figure 06: Global Drugs of Abuse Testing Market Value Share (%), by Region (2017)
Figure 7 Figure 07: Global Drugs of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 8 Figure 08: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 9 Figure 09: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2017–2027
Figure 10 Figure 10: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Testing Devices, 2017–2027
Figure 11 Figure 11: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2017–2027
Figure 12 Figure 12: Global Drugs of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 13 Figure 13: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 14 Figure 14: Global Drugs of Abuse Testing Sample Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva 2017–2027
Figure 15 Figure 15: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breath, 2017–2027
Figure 16: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2017–2027
Figure 17: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood, 2017–2027
Figure 18: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hair & Sweat 2017–2027
Figure 19: Global Drugs of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 20: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 21: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management Testing, 2017–2027
Figure 22: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Criminal Justice Testing, 2017–2027
Figure 23: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Workplace Screening, 2017–2027
Figure 24: Global Drugs of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 25: Global Drugs of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 26: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 27: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027
Figure 28: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-the-Spot Testing, 2017–2027
Figure 29: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Forensic Laboratories, 2017–2027
Figure 30: Global Drugs of Abuse Testing Market Value Share Analysis, by Region, 2018 and 2027
Figure 31: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Region, 2019-2027
Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027
Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 36: North America Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 37: North America Drug of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2027
Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 43: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 44: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027
Figure 45: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 46: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 47: Europe Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 48: Europe Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 49: Europe Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 50: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 51: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 52: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 53: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 54: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 55: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027
Figure 56: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 57: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 58: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 59: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 60: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 61: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 62: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 63: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 64: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 65: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 66: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027
Figure 67: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 68: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 69: Latin America Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 70: Latin America Drug of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2027
Figure 71: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 72: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 73: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 74: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 75: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 76: MEA Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 77: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2019-2027
Figure 78: MEA Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 79: MEA Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2027
Figure 80: MEA Drug of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2027
Figure 81: MEA Drug of Abuse Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 82: MEA Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 83: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2019-2027
Figure 84: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2019-2027
Figure 85: MEA Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2019-2027
Figure 86: MEA Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2019-2027
Figure 87: Global Drugs of Abuse Testing Market Share, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Drugs of Abuse Testing Market Outlook, 2019-2027
